Welcome to our dedicated page for Applied Therapeutics news (Ticker: APLT), a resource for investors and traders seeking the latest updates and insights on Applied Therapeutics stock.
Applied Therapeutics Inc. was a clinical-stage biopharmaceutical company focused on rare-disease drug development before its completed acquisition by Cycle Group Holdings Limited. Company news centered on govorestat, a central nervous system-penetrant Aldose Reductase Inhibitor for Classic Galactosemia, CMT-SORD and PMM2-CDG, including FDA interactions, clinical data updates and regulatory strategy.
Other recurring updates covered financial results, strategic alternatives, leadership changes, capital actions and the transaction process that resulted in Applied becoming part of the Cycle group.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.